Abstract
Background Mannan-binding lectin (MBL) is believed to be an important constituent of the innate immune system. It has been reported that the codon 54 G/A polymorphism of exon-1 affects the MBL2 gene and alters its activity. Aims We investigated the association between polymorphism of the MBL2 gene and gastric cancer risk as well as Helicobacter pylori infection in a Japanese population. Methods The study cohort comprised 388 gastric cancer patients and 144 healthy volunteers. Polymorphism at codon 54 of exon 1 of the MBL2 gene was investigated by PCR-based restriction fragment length polymorphism analysis. Results There was no significant difference in the distribution of the MBL2 genotype among the gastric cancer patients and healthy controls. However, the carrier of the A allele was more prevalent among patients with a more advanced stage gastric cancer [odds ratio (OR) 1.68, 95% confidence interval (CI) 1.05–2.67; P = 0.03] and also had an increased risk of gastric cancer among patients 65 years of age or younger (OR = 1.6, 95%CI = 1.01–2.52, <0.05). Conclusion The codon 54 polymorphism of the MBL2 gene is associated with more advanced phenotypes of gastric cancer and the risk of gastric cancer in Japanese patients 65 years of age or younger.
Similar content being viewed by others
References
NIH Consensus Conference (1992) Helicobacter pylori in peptic ulcer disease NIH consensus development panel on helicobacter pylori in peptic ulcer disease. JAMA 272:65–69
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131
Huang JQ, Sridhar S, Chen Y, Hunt RH (1998) Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114:1169–1179
Blaser MJ, Parsonnet J (1994) Parasitism by the “slow” bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 94:4–8
Turner MW, Hamvas RMJ (2000) Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2:305–322
Proulx F, Wagner E, Toledano B, Decaluwe H, Seidman EG, Rivard GE (2003) Mannan-binding lectin in children with Escherichia coli O157:H7 haemmorrhagic colitis and haemolytic uraemic syndrome. Clin Exp Immunol 133:360–363
Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW (2000) Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 68:688–693
Fujita T (2002) Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2:346–353
Turner MW (2003) The role of mannose-binding lectin in health and disease. Mol Immunol 40:423–429
Koch A, Melbye M, Sørensen P, Homøe P, Madsen HO, Mølbak K, Hansen CH, Andersen LH, Hahn GW, Garred P (2001) Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. J Am Med Assoc 285:1316–1321
Ahmad T, Tamboli CP, Jewell D, Colombel JF (2004) Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 126:1533–1549
Bak-Romaniszyn L, Cedzynski M, Szemraj J, St Swierzko A, Zeman K, Kaluzynski A, Planeta-Malecka I (2006) Mannnan-binding lectin in children with chronic gastritis. Scand J Immunol 63:131–135
Baccarelli A, Hou L, Chen J, Lissowska J, El-Omar EM, Grillo P, Giacomini SM, Yaeger M, Bernig T, Zatonski W, Fraumeni JF Jr, Chanock SJ, Chow WH (2006) Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int J Cancer 119:1970–1975
Scudiero O, Nardone G, Omodei D, Tatangelo F, Vitale DF, Salvatore F, Castaldo G (2006) A mannose-binding lectin-defective haplotype is a risk factor for gastric cancer. Clin Chem 52:1625–1627
Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW, Summerfield JA (1991) Molecular basis of opsonic defect in immunodeficient children. Lancet 337:1569–1570
Lipscombe RJ, Sumiya M, Hill AV, Lau YL, Levinsky RJ, Summerfield JA, Turner MW (1992) High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 9:709–715
Garred P, Larsen F, Madsen HO, Koch C (2003) Mannose-binding lectin deficiency–revisited. Mol Immunol 40:73–84
Lipscombe RJ, Beatty DW, Ganczakowski M, Goddard EA, Jenkins T, Lau YL, Spurdle AB, Sumiya M, Summerfield JA, Turner MW (1996) Mutations in the human mannose-binding protein gene: frequencies in several population groups. Eur J Hum Genet 4:13–19
Matsushita M, Hijikata M, Ohta Y, Iwata K, Matsumoto M, Nakao K, Kanai K, Yoshida N, Baba K, Mishiro S (1998) Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL. Arch Virol 143:645–651
Tsutsumi A, Sasaki K, Wakamiya N, Ichikawa K, Atsumi T, Ohtani K, Suzuki Y, Koike T, Sumida T (2001) Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjögren’s syndrome. Genes Immun 2:99–104
Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T, Nukiwa T (2004) Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest 126:95–99
Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49
Madsen HO, Garred P, Kurtzhals JA, Lamm LU, Ryder LP, Thiel S, Svejgaard A (1994) A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 40:37–44
Super M, Thiel S, Lu J, Levinsky RJ, Turner MW (1989) Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 25:1236–1239
Summerfield JA, Ryder S, Sumiya M, Thursz M, Gorchein A, Monteil MA, Turner MW (1995) Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 345:886–889
Turner MW (2003) Role of mannose-binding lectin in health and disease. Mol Immunol 40:423–429
Larsen F, Madsen HO, Sim RB, Koch C, Garred P (2004) Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem 279:21302–21311
Boniotto M, Braida L, Baldas V, Not T, Ventura A, Vatta S, Radillo O, Tedesco F, Percopo S, Montico M, Amoroso A, Crovella S (2005) Evidence of a correlation between mannose binding lectin and celiac disease: a model for other autoimmune diseases. J Mol Med 83:308–315
Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S (2004) Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 351:260–267
Wang FY, Arisawa T, Tahara T, Nagasaka M, Fujita H, Hirata I, Nakano H (2008) The role of Mannan-binding lectin (MBL) gene polymorphism in ulcerative colitis. J Clin Biochem Nutr 42:54–58
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, FY., Tahara, T., Arisawa, T. et al. Mannan-binding Lectin (MBL) Polymorphism and Gastric Cancer Risk in Japanese Population. Dig Dis Sci 53, 2904–2908 (2008). https://doi.org/10.1007/s10620-008-0249-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-008-0249-3